Published in Am J Obstet Gynecol on December 01, 1992
Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer (1996) 0.94
Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer. J Biomed Opt (2013) 0.81
Animal models for photodynamic therapy (PDT). Biosci Rep (2015) 0.79
Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med (1979) 9.80
The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature (1987) 8.28
A role for exon sequences and splice-site proximity in splice-site selection. Cell (1986) 6.41
The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans. Nature (2000) 5.57
Intron sequences involved in lariat formation during pre-mRNA splicing. Cell (1985) 5.30
Splicing is required for rapid and efficient mRNA export in metazoans. Proc Natl Acad Sci U S A (1999) 4.26
SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol (1994) 4.25
An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev (1991) 3.99
Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature (2001) 3.94
The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell (1997) 3.68
Limitation of medical care: an ethnographic analysis. J Clin Ethics (1993) 3.45
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 3.17
A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction. EMBO J (1994) 3.17
Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev (1992) 3.16
Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev (1996) 3.06
Evaluation of the effect of WIC supplemental feeding on birth weight. J Am Diet Assoc (1982) 2.92
A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev (1993) 2.83
Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro. Mol Cell Biol (1992) 2.66
A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol Cell Biol (1998) 2.62
Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev (1998) 2.30
Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly. Mol Cell Biol (1996) 2.29
Collecting data in general practice: need for standardisation. BMJ (1996) 2.29
Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. Mol Cell (2000) 2.27
Resolution of the mammalian E complex and the ATP-dependent spliceosomal complexes on native agarose mini-gels. RNA (1999) 2.06
Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol Cell Biol (1994) 2.03
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 2.00
General practitioners' views about the statutory annual practice report. BMJ (1994) 1.97
Identification of both shared and distinct proteins in the major and minor spliceosomes. Science (1999) 1.96
A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn. N Engl J Med (1976) 1.96
Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke (1992) 1.89
Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals. EMBO J (1997) 1.85
A two-step mechanism for 5' and 3' splice-site pairing. Nature (1995) 1.85
Identification of a functional mammalian spliceosome containing unspliced pre-mRNA. Proc Natl Acad Sci U S A (1988) 1.85
An X-ray and electron microscope study of tropomyosin. Biochem J (1948) 1.85
Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer (1985) 1.77
Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. Mol Cell Biol (1999) 1.73
Correspondence between a mammalian spliceosome component and an essential yeast splicing factor. Science (1993) 1.71
Asthma specific quality of life scale in a study of salmeterol hydroxynaphthoate. Br J Gen Pract (1991) 1.67
Association of guide RNA binding protein gBP21 with active RNA editing complexes in Trypanosoma brucei. Mol Cell Biol (1998) 1.66
WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Proc Natl Acad Sci U S A (1998) 1.64
Honey stimulates inflammatory cytokine production from monocytes. Cytokine (2003) 1.63
An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing. Mol Cell Biol (2001) 1.57
The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. Genes Dev (1994) 1.57
Human homologs of yeast prp16 and prp17 reveal conservation of the mechanism for catalytic step II of pre-mRNA splicing. EMBO J (1998) 1.56
Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52
Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med (1982) 1.48
Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol (1979) 1.43
In situ and small invasive breast cancer register in Victoria, 1988 to 1992: tumour characteristics and patient management. ANZ J Surg (2001) 1.42
Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl (2003) 1.41
The RNA splicing factor hSlu7 is required for correct 3' splice-site choice. Nature (1999) 1.40
Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 1.40
Observation of an antimatter hypernucleus. Science (2010) 1.38
Stimulation of TNF-alpha release in monocytes by honey. Cytokine (2001) 1.30
Human step II splicing factor hSlu7 functions in restructuring the spliceosome between the catalytic steps of splicing. Genes Dev (1999) 1.30
Transposon-specified site-specific recombination. Proc Natl Acad Sci U S A (1982) 1.28
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Nomenclature for ion channel subunits. Science (2001) 1.26
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol (1992) 1.26
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer (1986) 1.25
Accumulation of a novel spliceosomal complex on pre-mRNAs containing branch site mutations. Mol Cell Biol (1995) 1.24
Specific protein-protein interactions between the essential mammalian spliceosome-associated proteins SAP 61 and SAP 114. Proc Natl Acad Sci U S A (1994) 1.16
Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol (1998) 1.15
Teaching pelvic examination to second-year medical students using programmed patients. Am J Obstet Gynecol (1975) 1.13
A Ran-independent pathway for export of spliced mRNA. Nat Cell Biol (2001) 1.10
Literacy and performance on the Mini-Mental State Examination. J Am Geriatr Soc (1995) 1.08
Interactions in the fourth dimension. Biotechnology (N Y) (1992) 1.08
Leiomyomatosis peritonealis disseminata treated with a gonadotropin-releasing hormone agonist. A case report. Am J Obstet Gynecol (1992) 1.07
Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med (1995) 1.06
The effectiveness of waiting room notice-boards as a vehicle for health education. Fam Pract (1994) 1.02
Immunohistochemical staining for DNA topoisomerase II in frozen and formalin-fixed paraffin-embedded human tissues. Mod Pathol (1994) 1.02
Polymorphism in the STAT6 gene encodes risk for nut allergy. Genes Immun (2002) 1.02
Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma--a diagnostic tool in minimally invasive biopsies. J Pathol (1996) 1.01
Association of U2 snRNP with the spliceosomal complex E. Nucleic Acids Res (1997) 1.01
Guidelines on the management of asthma. Thorax (1993) 1.01
A new mutation in IVS-1 of the human beta globin gene causing beta thalassemia due to abnormal splicing. Blood (1987) 1.00
Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem Photobiol (1989) 1.00
Multiple systems organ failure: I. The basal state. J Trauma (1981) 0.99
Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: a prospective, nonrandomized, cohort study and meta-analysis. Fertil Steril (1994) 0.99
Erythema gyratum repens. Am J Med Sci (2001) 0.99
Demographic characteristics and primary health care utilization patterns of strictly orthodox Jewish and non-Jewish patients. Fam Pract (2000) 0.99
Aging, abstinence, and medical risk factors in the prediction of neuropsychologic deficit among long-term alcoholics. Arch Gen Psychiatry (1984) 0.98
Role of leucocytes in damage to the vascular endothelium during ischaemia-reperfusion injury. Br J Biomed Sci (2006) 0.98
Members of a family of proteins (the RD family) detected by a U1 70K monoclonal antibody are present in spliceosomal complexes. Nucleic Acids Res (1995) 0.98
Ethical and clinical issues with Native-American elders. End-of-life decision making. Clin Geriatr Med (1995) 0.97
The epidermal-dermal junction of normal human skin as seen in freeze-etch preparations. Br J Dermatol (1970) 0.97
Argon laser therapy of endometriosis: a review of 92 consecutive patients. Fertil Steril (1987) 0.97
Carcinoid-islet cell tumors of the duodenum. Ann Surg (1967) 0.96
Skeletal myogenesis: the preferred pathway of chick embryo epiblast cells in vitro. Dev Biol (1996) 0.96
Risk profile of soldiers aged under 40 with coronary heart disease. Br Med J (Clin Res Ed) (1985) 0.96
Ethanol elimination rates in an ED population. Am J Emerg Med (1995) 0.96
Inactivation and mutagenesis of herpes virus by photodynamic treatment with therapeutic dyes. Photochem Photobiol (1989) 0.96
A randomized, prospective analysis of five sperm preparation techniques before intrauterine insemination of husband sperm. Fertil Steril (1998) 0.95
Pregnancy following uterine fibroid embolization. Int J Gynaecol Obstet (2001) 0.95
Properties and biosynthesis of cyclopropane fatty acids in Escherichia coli. J Bacteriol (1979) 0.94
Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Clin Cancer Res (2000) 0.93
Immunoregulatory properties of antigenic fragments from bovine serum albumin. Cell Immunol (1983) 0.93